Literature DB >> 20456358

Risk factors for venous thrombosis - current understanding from an epidemiological point of view.

Willem M Lijfering1, Frits R Rosendaal, Suzanne C Cannegieter.   

Abstract

Epidemiological research throughout the last 50 years has provided the long list of risk factors for venous thrombosis that are known today. Although this has advanced our current understanding about the aetiology of thrombosis, it does not give us all the answers: many people have several of these risk factors but never develop thrombosis; others suffer from thrombosis but have none. In this review, we discuss how risk factors for venous thrombosis can be interpreted with use of several epidemiological models. We comment on how to explain why risk factors for first venous thrombosis differ from recurrent venous thrombosis, and use a causal model to better understand risk of first and recurrent venous thrombosis.

Entities:  

Mesh:

Year:  2010        PMID: 20456358     DOI: 10.1111/j.1365-2141.2010.08206.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  47 in total

1.  Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains.

Authors:  Amit Prabhakar; Tathagata Chatterjee; Nitin Bajaj; Tarun Tyagi; Anita Sahu; Neha Gupta; Babita Kumari; Velu Nair; Bhuvnesh Kumar; Mohammad Zahid Ashraf
Journal:  Blood Adv       Date:  2019-11-26

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

4.  Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.

Authors:  Ashfaque A Memon; Kristina Sundquist; Xiao Wang; Peter J Svensson; Jan Sundquist; Bengt Zöller
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

5.  Ischemic stroke in a patient with hetrozygous factor v leiden mutation: an uncommon association.

Authors:  P S Ghalaut; Joginder Duhan; Vikas Chaudhary; Hemant Krishan Dahiya; Sumin Kaushik; Manisha Sharma; Jitendra Kumar Pehalajani
Journal:  Indian J Hematol Blood Transfus       Date:  2014-05-04       Impact factor: 0.900

6.  Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.

Authors:  Ghaith Abu-Zeinah; Clara Oromendia; Maria T DeSancho
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

7.  Elderly patients with intertrochanteric fractures after intramedullary fixation : Analysis of risk factors for calf muscular vein thrombosis.

Authors:  Hao Su; Hongzhi Liu; Juan Liu; Xin Wang
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

8.  A natural language processing algorithm to define a venous thromboembolism phenotype.

Authors:  Eugenia R McPeek Hinz; Lisa Bastarache; Joshua C Denny
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

9.  Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Aaron R Folsom; Pamela L Lutsey; Vijay Nambi; Christopher R deFilippi; Susan R Heckbert; Mary Cushman; Christie M Ballantyne
Journal:  Vasc Med       Date:  2014-02       Impact factor: 3.239

10.  Multiple Venous Thromboses Presenting as Mechanical Low Back Pain in an 18-Year-Old Woman.

Authors:  Andrée-Anne Marchand; Jean-Alexandre Boucher; Julie O'Shaughnessy
Journal:  J Chiropr Med       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.